Site map

Research-use compounds with GBP pricing.

GHK-Cu is associated with copper peptide, matrix, and skin-model research.

BPC-157 is commonly referenced in repair and gastrointestinal research.

TB-500 is associated with thymosin beta-4 fragment and cell-migration research.

KPV is a tripeptide often discussed in inflammation and barrier-model research.

MT2 is associated with melanocortin research.

Tesamorelin is associated with GHRH analogue and growth-hormone research.

PT-141 is associated with melanocortin receptor research.

MOTS-C is associated with mitochondrial and metabolic research.

Ipamorelin is associated with ghrelin-receptor and growth-hormone secretagogue research.

Semax is associated with ACTH-fragment neuropeptide research.

Selank is associated with tuftsin-analogue neuropeptide research.

NAD+ is associated with redox and mitochondrial research.

MT-1 is associated with MC1R-selective melanocortin research — distinct from MT2.

A combined BPC-157 and TB-500 research format — distinct from individual BPC-157 and TB-500 listings.

Epitalon is a tetrapeptide often discussed in ageing-model and telomere-adjacent research.

101 editorial reference entries.

Chemically modified form of Selank studied in anxiety and cognition research.

Three-amino-acid Khavinson bioregulator identified in thymus extract, studied in immune ageing research.

Purified FSH and LH preparation from urine, long used in fertility medicine and endocrine research.

Vendor blend of four cognitive-research peptides. The blend itself has never been studied.

Chemically stabilised Semax variant. Marketed as an improvement, but studied far less than Semax itself.

Three-amino-acid Khavinson bioregulator studied in neuroprotection and cognitive research.

Investigational triple hormone receptor agonist studied in obesity and metabolic research.

Experimental compound studied as an exercise mimetic in mice. Not a peptide; no human data exists.

Small molecule studied for its effect on NAD+ levels and fat metabolism. Not a peptide.

Parathyroid hormone analogue approved for osteoporosis and studied in bone research.

Experimental myostatin-blocking protein whose clinical development was halted on safety grounds.

Modified Semax derivative studied in cognition and neuroprotection research.

Experimental fat-targeting compound whose development stopped after kidney safety signals.

Copper-binding tripeptide studied in hair follicle and skin research.

AMPK-activating compound studied as an exercise mimetic; banned in competitive sport.

Fragment of growth hormone studied for effects on fat metabolism, with disappointing trial results.

Engineered peptide studied in nerve damage and tissue protection research.

Simplified relaxin analogue studied in fibrosis and cardiovascular research.

Mitochondrial uncoupler studied in obesity research as a safer alternative to older uncouplers.

Synthetic gastric peptide widely studied in animal tissue-repair models, with very limited human data.

Short peptide from the Khavinson bioregulator programme, studied in lung tissue research.

Long-acting amylin analogue studied on its own and combined with semaglutide in obesity trials.

Khavinson bioregulator peptide studied in cardiac tissue research.

Khavinson bioregulator tripeptide studied in cartilage and connective tissue research.

Peptide preparation derived from pig brain tissue, used clinically in some countries for stroke and dementia.

Khavinson bioregulator tripeptide studied in respiratory tissue research.

Short-acting growth hormone-releasing hormone analogue studied in growth hormone research.

Long-acting version of the same GHRH analogue, modified to stay in circulation for days.

Vendor combination of two growth hormone compounds. No trials exist on the combination itself.

Khavinson bioregulator peptide studied in brain and nerve tissue research.

Naturally occurring dipeptide studied for its role in regulating how much IGF-1 is available.

Angiotensin IV-derived compound studied for synapse formation in animal models of cognitive decline.

Repair, matrix, and tissue-model research references.

Neuropeptide and cognitive-model research references.

Growth-hormone and endocrine research references.

Mitochondrial, ageing-model, and cellular research references.

Appetite, body weight and blood-sugar research compounds.

Growth hormone, IGF-1 and hormone-signalling research.

Wound healing, tendon, gut and blood-vessel research.

Memory, mood, stress and neuroprotection research.

Mitochondria, cellular ageing and NAD+ research.

Immune signalling, thymic peptides and antimicrobial research.

Reproductive hormones and sexual-response research.

Skin repair, collagen, pigmentation and hair research.

AXIOM UK research catalogue. Peptide references and available certificates.

Side-by-side research references for related compounds.

How AXIOM presents research-use compounds and records.

COA archive and testing methodology.

Research use, ordering, and record questions.

Editorial standards for database entries.

Verified Purchase reviews from AXIOM customers.